363 related articles for article (PubMed ID: 28216034)
1. The Vitiligo Working Group recommendations for narrowband ultraviolet B light phototherapy treatment of vitiligo.
Mohammad TF; Al-Jamal M; Hamzavi IH; Harris JE; Leone G; Cabrera R; Lim HW; Pandya AG; Esmat SM
J Am Acad Dermatol; 2017 May; 76(5):879-888. PubMed ID: 28216034
[TBL] [Abstract][Full Text] [Related]
2. Exploring the gaps in the evidence-based application of narrowband UVB for the treatment of vitiligo.
Madigan LM; Al-Jamal M; Hamzavi I
Photodermatol Photoimmunol Photomed; 2016 Mar; 32(2):66-80. PubMed ID: 26662644
[TBL] [Abstract][Full Text] [Related]
3. Evaluation for Skin Cancer and Precancer in Patients With Vitiligo Treated With Long-term Narrowband UV-B Phototherapy.
Bae JM; Ju HJ; Lee RW; Oh SH; Shin JH; Kang HY; Park JH; Kim HJ; Jeong KH; Lee HJ; Lee S; Kim DH; Lee DY; Kim YC; Choi GS; Kim KH; Park CJ; Choi CW;
JAMA Dermatol; 2020 May; 156(5):529-537. PubMed ID: 32159729
[TBL] [Abstract][Full Text] [Related]
4. Psoralen and narrowband UVB combination provides higher efficacy in treating vitiligo compared with narrowband UVB alone: A randomised clinical trial.
Zabolinejad N; Maleki M; Salehi M; Ashrafi Z; Molkara S; Layegh P
Australas J Dermatol; 2020 Feb; 61(1):e65-e69. PubMed ID: 31651037
[TBL] [Abstract][Full Text] [Related]
5. Targeted broadband ultraviolet b phototherapy produces similar responses to targeted narrowband ultraviolet B phototherapy for vitiligo: a randomized, double-blind study.
Asawanonda P; Kijluakiat J; Korkij W; Sindhupak W
Acta Derm Venereol; 2008; 88(4):376-81. PubMed ID: 18709309
[TBL] [Abstract][Full Text] [Related]
6. The impact of positive antinuclear antibody on narrowband ultraviolet B phototherapy in patients with vitiligo: A retrospective chart review.
Nahhas AF; Nartker NT; Braunberger TL; Jacobsen G; Hamzavi IH
Photodermatol Photoimmunol Photomed; 2019 Mar; 35(2):106-109. PubMed ID: 30267591
[TBL] [Abstract][Full Text] [Related]
7. The Safety and Efficacy of Narrow Band Ultraviolet B Treatment in Dermatology: A Review.
Sokolova A; Lee A; D Smith S
Am J Clin Dermatol; 2015 Dec; 16(6):501-31. PubMed ID: 26369540
[TBL] [Abstract][Full Text] [Related]
8. Narrowband UVB phototherapy in vitiligo: evaluation of results in 53 patients.
Percivalle S; Piccino R; Caccialanza M; Forti S
G Ital Dermatol Venereol; 2008 Feb; 143(1):9-14. PubMed ID: 18833047
[TBL] [Abstract][Full Text] [Related]
9. A pilot study of combined oral minocycline and narrowband UVB phototherapy in vitiligo: A randomized, double-blind, placebo-controlled trial.
Charoenpongpun N; Kamanamool N; Udompataikul M; Khunkhet S; Kanokrungsee S
Dermatol Ther; 2022 Aug; 35(8):e15596. PubMed ID: 35608017
[TBL] [Abstract][Full Text] [Related]
10. Tetrahydrocurcuminoid cream plus targeted narrowband UVB phototherapy for vitiligo: a preliminary randomized controlled study.
Asawanonda P; Klahan SO
Photomed Laser Surg; 2010 Oct; 28(5):679-84. PubMed ID: 20961233
[TBL] [Abstract][Full Text] [Related]
11. Narrowband ultraviolet B phototherapy in childhood vitiligo: evaluation of results in 28 patients.
Percivalle S; Piccinno R; Caccialanza M; Forti S
Pediatr Dermatol; 2012; 29(2):160-5. PubMed ID: 22329609
[TBL] [Abstract][Full Text] [Related]
12. Psoralen-narrowband UVB phototherapy for the treatment of vitiligo in comparison to narrowband UVB alone.
Bansal S; Sahoo B; Garg V
Photodermatol Photoimmunol Photomed; 2013 Dec; 29(6):311-7. PubMed ID: 24118425
[TBL] [Abstract][Full Text] [Related]
13. Keratoacanthoma in vitiligo lesion after UVB narrowband phototherapy.
Brazzelli V; Barbagallo T; Prestinari F; Vassallo C; Agozzino M; Vailati F; Cespa M; Borroni G
Photodermatol Photoimmunol Photomed; 2006 Aug; 22(4):211-3. PubMed ID: 16869872
[TBL] [Abstract][Full Text] [Related]
14. Psoralen and ultraviolet A and narrow-band ultraviolet B in inducing stability in vitiligo, assessed by vitiligo disease activity score: an open prospective comparative study.
Bhatnagar A; Kanwar AJ; Parsad D; De D
J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1381-5. PubMed ID: 17958845
[TBL] [Abstract][Full Text] [Related]
15. Targeted ultraviolet B phototherapy in vitiligo: A comparison between once-weekly and twice-weekly treatment regimens.
Majid I; Imran S
Indian J Dermatol Venereol Leprol; 2015; 81(6):600-5. PubMed ID: 26515839
[TBL] [Abstract][Full Text] [Related]
16. Effects of a preceding fractional carbon dioxide laser on the outcome of combined local narrowband ultraviolet B and topical steroids in patients with vitiligo in difficult-to-treat areas.
Vachiramon V; Chaiyabutr C; Rattanaumpawan P; Kanokrungsee S
Lasers Surg Med; 2016 Feb; 48(2):197-202. PubMed ID: 26175036
[TBL] [Abstract][Full Text] [Related]
17. Tacalcitol: a useful adjunct to narrow-band ultraviolet-B phototherapy in vitiligo.
Sahu P; Jain VK; Aggarwal K; Kaur S; Dayal S
Photodermatol Photoimmunol Photomed; 2016 Sep; 32(5-6):262-268. PubMed ID: 27552149
[TBL] [Abstract][Full Text] [Related]
18. Comparison between 308-nm monochromatic excimer light and narrowband UVB phototherapy (311-313 nm) in the treatment of vitiligo--a multicentre controlled study.
Casacci M; Thomas P; Pacifico A; Bonnevalle A; Paro Vidolin A; Leone G
J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):956-63. PubMed ID: 17659006
[TBL] [Abstract][Full Text] [Related]
19. Are very high cumulative doses of narrowband UVB safe in vitiligo?
Momen S; Sarkany R
Photodermatol Photoimmunol Photomed; 2017 Jul; 33(4):220-221. PubMed ID: 28370729
[No Abstract] [Full Text] [Related]
20. Novel topical cream delivers safe and effective sunlight therapy for vitiligo by selectively filtering damaging ultraviolet radiation.
Goren A; Salafia A; McCoy J; Keene S; Lotti T
Dermatol Ther; 2014; 27(4):195-7. PubMed ID: 24548413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
